Patents by Inventor Marta Aparicio

Marta Aparicio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9504729
    Abstract: Methods of inhibiting undesired angiogenesis are provided, which methods include administering to a subject a therapeutically effective amount of at least one of the compounds described herein, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: November 29, 2016
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Enrique Zudaire, Marta Aparicio, Frank Cuttitta
  • Publication number: 20160030508
    Abstract: Methods of inhibiting undesired angiogenesis are provided, which methods include administering to a subject a therapeutically effective amount of at least one of the compounds described herein, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 13, 2015
    Publication date: February 4, 2016
    Applicant: The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Enrique Zudaire, Marta Aparicio, Frank Cuttitta
  • Patent number: 9186365
    Abstract: Methods of inhibiting undesired angiogenesis are provided, which methods include administering to a subject a therapeutically effective amount of at least one of the compounds described herein, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: November 17, 2015
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Enrique Zudaire, Marta Aparicio, Frank Cuttitta
  • Publication number: 20120129775
    Abstract: Methods of inhibiting undesired angiogenesis are provided, which methods include administering to a subject a therapeutically effective amount of at least one of the compounds described herein, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 30, 2010
    Publication date: May 24, 2012
    Inventors: Enrique Zudaire, Marta Aparicio, Frank Cuttitta